adult giant cell glioblastoma
Showing 1 - 25 of >10,000
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)
Completed
- Adult Giant Cell Glioblastoma
- +3 more
- bevacizumab
- radiation therapy
-
Birmingham, Alabama
- +30 more
Dec 27, 2022
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Philadelphia (drug, radiation, other)
Completed
- Adult Giant Cell Glioblastoma
- +2 more
- gefitinib
- +2 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Cincinnati, Cleveland (biological, device, other)
Completed
- Adult Giant Cell Glioblastoma
- +3 more
- Bevacizumab
- +2 more
-
Cincinnati, Ohio
- +2 more
Jul 22, 2020
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)
Recruiting
- Glioblastoma
- TH-1 Dendritic Cell Immunotherapy
-
Camden, New Jersey
- +1 more
Jun 27, 2022
Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)
Not yet recruiting
- Glioblastoma
- Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
-
Gainesville, FloridaUniversity of Florida Health
Jul 29, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in United States (drug,
Terminated
- Adult Anaplastic Astrocytoma
- +4 more
- Temozolomide
- +3 more
-
Chicago, Illinois
- +4 more
Feb 27, 2020
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)
Completed
- Malignant Glioma
- +3 more
- Dendritic Cell Vaccine
- +3 more
-
Miami, FloridaUniversity of Miami
Jul 19, 2022
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)
Active, not recruiting
- Advanced Solid Tumors
- +15 more
- (no location specified)
Sep 16, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Nov 3, 2021
Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,
Not yet recruiting
- Glioblastoma Multiforme
- +3 more
- P140K-MGMT
- +5 more
-
Bethesda, Maryland
- +1 more
Jul 4, 2022
Brain Tumor Adult Trial in Birmingham (DRI cell therapy)
Recruiting
- Brain Tumor Adult
- DRI cell therapy
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 1, 2022
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)
Enrolling by invitation
- Glioblastoma
- +4 more
-
Seongnam, Kyunggido, Korea, Republic ofBundang CHA Medical Center
Jan 6, 2022